Skip to main content
PLOS One logoLink to PLOS One
. 2024 Dec 30;19(12):e0308817. doi: 10.1371/journal.pone.0308817

Bioinformatics analysis of myelin-microbe interactions suggests multiple types of molecular mimicry in the pathogenesis of multiple sclerosis

Ali Bigdeli 1, Mostafa Ghaderi-Zefrehei 2, Bluma J Lesch 3, Mehrdad Behmanesh 4, S Shahriar Arab 1,*
Editor: Awatif Abid Al-Judaibi5
PMCID: PMC11684644  PMID: 39775333

Abstract

Multiple sclerosis (MS) is a devastating autoimmune disease that leads to the destruction of the myelin sheath in the human central nervous system (CNS). Infection by viruses and bacteria has been found to be strongly associated with the onset of MS or its severity. We postulated that the immune system’s attack on the myelin sheath could be triggered by viruses and bacteria antigens that resemble myelin sheath components. An in-silico bioinformatics approach was undertaken in order to identify viral and bacterial antigens that resemble myelin oligodendrocyte glycoprotein (MOG) and myelin basic protein (MBP). To this end, we simultaneously analyzed both protein structures and amino acid sequences from viral and bacterial proteins and compared them to MOG and MBP. Possible associations between MBP and human parvovirus B19 (HPV-B19) and adeno-associated virus 4 (AAV-4) capsid protein structures were identified. MBP and MOG were associated with antigens from different viruses and bacteria, including Aspergillus species, Lactobacillus, Burkholderia, Clostridium, Schizosaccharomyces, SARS-CoV-2, and some gut flora metabolites. We also identified similarities between MBP and MOG proteins and bile salt hydrolase (BSH), glycosyltransferase (WcfQ), and Wzy enzymes. Identical amino acids between MBP and BSH at the active site, and protected amino acids in MOG aligning with WcfQ and Wzy enzymes were observed. Overall, our results offer valuable insights into the role of different viral and bacterial protein antigens in MS pathogenesis and suggest the possibility of identifying new therapeutic targets using in silico bioinformatics approaches. Our proposed approach could also likely be adapted for other CNS diseases in order to develop new biological insights and treatments.

Introduction

Multiple sclerosis (MS) is a central nervous system (CNS) disease that produces inflammatory plaques in the brain, spinal cord, and optic nerve, with associated nerve cell degeneration [1, 2]. The underlying cause of MS is autoimmune attack on myelin, the insulating layer that allows nerves to send electrical impulses over long distances. Myelin is made up of specialized glial cell membranes that wrap multiple times around a neuron’s axon sheath and contain specialized proteins and lipids [3]. Some viruses including Epstein-Barr virus (EBV), human herpesvirus 6 (HHV-6), and the human endogenous retroviruses (HERV) family, as well as bacteria like Helicobacter pylori, Chlamydia pneumonia, and Staphylococcus aureus enterotoxins, are associated with the development or exacerbation of MS [4]. This association has been postulated to be based on molecular mimicry by the viral or bacterial proteins, a process by which similar antigenic compounds generated by microorganisms cause autoimmune diseases by mimicking endogenous proteins and triggering an immune response [5, 6]. Molecular mimicry by pathogens has attracted significant attention to finding interactions between infectious agents and MS [710]. Two myelin proteins thought to be targets for a molecular mimicry mechanisms are myelin basic protein (MBP) and myelin oligodendrocyte glycoprotein (MOG) [10, 11].

Numerous studies have investigated the immune response in MS patients, revealing that the presence of peptides from two proteins—one from Epstein-Barr Virus (EBV) and the other from the bacterium Mycobacterium paratuberculosis (MAP)—in the cerebrospinal fluid and serum trigger autoimmunity [12]. EBV, in particular, has been strongly associated with the onset of MS [13]. The interferon regulatory factor 5 protein (IRF-5) epitope matches EBV and MAP antigens and elicits a humoral immune response in MS patients [14]. Additional peptides derived from EBV and MAP that cross-react with myelin proteins have been discovered through the use of myelin-targeting antibodies and are thought to be involved in the progression of MS [15, 16]. In addition to EBV, other viral pathogens including Parvovirus B19 species (Parvoviridae virus family, HPV-B19) have been linked to both autoimmune disorders and CNS diseases, including MS [1721]. HPV-B19 shares a secondary and tertiary structure with serotype 4 of an adeno-associated virus (AAV), also from the Parvoviridae family. There is active research into the structure and function of AAV capsid proteins with the goal of developing approaches to modulate their immune responses [2224]. Additionally, there are several viruses in the herpesviridae family, including human herpesvirus 6 (HHV-6), which have been implicated in the development of autoimmune disorders including MS [25, 26].

In bacteria, the epsilon toxin of the pathogen Clostridium perfringens is known to cause brain damage in both animals and humans by affecting their neurological systems [27]. The presence of antibodies to epsilon toxin in some MS patients has been reported [28], suggesting that C. perfringens epsilon toxin could also play a role in the development of MS in some individuals. In addition, synergy between native gut bacteria Lactobacillus reuteri and OTU0002 Erysipelotrichaceae in the mouse can lead to intestinal T-cell responses to MOG in the CNS, potentially resulting in autoimmune encephalitis [29]. Part of the MOG and MBP protein sequences were also found to be similar to enzyme sequences from gut bacteria involved in butyric acid and polysaccharide A metabolism, including bile salt hydrolase (BSH) [30, 31].

Our aim in this study was to investigate the structural and sequence relationships between microorganism-derived proteins and myelin-based proteins. We evaluated structural relationships and amino acid sequence similarity between proteins from the viral and bacterial microorganisms discussed above and MOG and MBP by means of in-silico bioinformatics. In the first step, we focused on the 3D structure, conserved regions, and sequence association of MBP with viral capsid protein structures of HPV B19 and AAV-4. We then reviewed previous studies to identify parts of the myelin protein amino acid sequences that contribute to cases of molecular mimicry between microorganism proteins and MOG and MBP, and found additional pathogenic microorganisms where structural proteins contained matched peptide sequences, suggesting that these pathogens could also trigger autoimmunity. Finally, we also identified similar peptide sequences in proteins from native gut microbiota and metabolites, where mimicry could cause dysbiosis in the intestine and induce an immune system response. Together, we identified potential associations with specific microorganisms and antigens that could lead to the development of new strategies for treating and preventing autoimmune disorders, particularly MS.

Materials and methods

Fig 1 shows a comprehensive overview of the study methodology.

Fig 1. Study pipeline overview.

Fig 1

Extraction of data related to MBP

The amino acid sequence of MBP (accession number P02686) was obtained from UniProt (https://www.uniprot.org/). The sequence was checked in the Research Collaboratory for Structural Bioinformatics (RCSB) [32] database for the presence of a tertiary structure. Examination of the Basic Local Alignment Search Tool (BLAST) [33] and Protein Data Bank (PDB) [34] databases revealed that there are only a few known 3D structures within the 304 amino acids of the full-length protein (Fig 2).

Fig 2. The current PDB structures related to a portion of the MBP sequence.

Fig 2

The tertiary structures of MBP were obtained from AlphaFold (https://alphafold.ebi.ac.uk/), which uses a deep learning approach that leverages physical, biological, and bioinformatics information about protein structure and multiple sequence alignments [35, 36].

MBP alignment with HPV-B19 and AAV-4

The HPV-B19 and AAV-4 viral capsid protein sequences were obtained from UniProt (accession number Q9PZT0 and O41855, respectively) and aligned separately with MBP using the PRALINE server [37, 38] which takes into account the predicted secondary structure during the alignment of amino acid sequences. The results of this alignment were used for further investigation of the tertiary structures. To evaluate the obtained scores and classify the amino acid alignments information, the position of each amino acid in the 3D structure was analyzed using the YASARA software [39]. The software’s structural overlap feature was utilized to analyze similarities between the two-3D viral capsid protein structures using pairwise alignment from the MUSTANG algorithm [40].

Extraction of data related to MOG

Data on MOG were retrieved from the UniProt database using the human and mouse codes Q16653 and Q61885, respectively. In mice, the YRSPFSRVV motif is linked to the development of autoimmune encephalitis of the CNS and, as a result, MS [29]. This MOG motif in mice has a specified tertiary structure that was discovered using X-ray crystallography [41]. The equivalent motif in human is YRPPFSRVV, and the tertiary structure of this human domain is also included in the PDB database.

Predicting antibody epitope

In order to predict antigenic regions in each of the proteins studied, we tested three online tools: Bepipred Linear Epitope Prediction 2.0 (BepiPred-2.0) (Sequential B-Cell Epitope Predictor) [42], Bcepred (http://crdd.osdd.net/raghava/bcepred/) [43] and the Kolaskar & Tongaonkar antigenicity scale [44]. However, we observed discrepancies in the results obtained from each software program. To ensure consistency and avoid confusion, we decided to report data from only one software program. We selected the BepiPred-2.0 method as the preferred tool for our analysis, based on the superior performance of BepiPred-2.0 compared to other available tools for predicting B-cell epitopes.

Microbe motifs and MS

The information used as input in the alignments and adaptations of this study was carefully selected to ensure accuracy and reliability. Table 1 displays the data gathered from the investigations carried out in [12, 15].

Table 1. The sequence information for Mycolicibacterium paratuberculosis, Epstein-Barr virus, and Homo sapiens, along with the corresponding protein names for each sequence (derived from previous studies) [12, 15].

Organism Sequence information Protein name reference
Mycolicibacterium paratuberculosis (strain ATCC BAA-968 / K-10) 121 PGRRPFTRKELQ 132 Tyr recombinase domain-containing protein (MAP_0106) [12]
Epstein-Barr virus (strain B95-8) (HHV-4) 400 PGRRPFFHPVGEAD 413 Epstein-Barr nuclear antigen 1 (EBNA1)
Homo sapiens (Human) 85 PGSRPHLIRLFSRD 98 MBP (MBP_HUMAN)
Mycolicibacterium paratuberculosis (strain ATCC BAA-968 / K-10) 18 AVVPVLAYAAARLLL 32 Uncharacterized protein (MAP_4027) [15]
Epstein-Barr virus (strain B95-8) (HHV-4) 305 AVPVLAFDAARLRLLE 320 Inner tegument protein (BOLF1)
Homo sapiens (Human) 424 RLLLEMFSGEL 434 Interferon regulatory factor 5 (IRF5_HUMAN)

Table 2 presents the sequence similarity information between Lactobacillus and OUT002 proteins and MOG.

Table 2. Protein sequence similarity and conserved amino acids, with bolded residues such as Arginine, Phenylalanine, Arginine, and Valine (observed in the cited study) [29].

Organism Sequence information Protein name
Lactobacillus reuteri 172 K R EG F V RV Q 180 UvrABC system protein A
Lactobacillus reuteri (strain DSM 20016) 324 G R LT F L RV Y 332 Elongation factor G
Lactobacillus reuteri (strain DSM 20016) 122 K R IA F S RV Y 130 Amino acid ABC transporter substrate-binding protein
OTU0002 N. A E R DG F T RV L N. A Xaa-Pro Aminopeptidase
Erysipelotrichaceae
Mus musculus 68 Y R SP F S RV V 76 MOG (MOG_MOUSE)

Table 3 summarizes the other key information gathered from previous research that served as a reference for the present study, including details on the proteins and pathogenic motifs investigated in this study. PRALINE server was used for finding the sequence alignments [37, 38]. The amino acid alignment score ranges from 0 to 10, where 0 indicates no similarity and a star (10) indicates identity.

Table 3. A summary of the data gathered from previous researches.

Protein Sequence Organism References
U24 protein MDRPRTPPPSYSE Human herpesvirus 6B (strain Z29) (HHV-6 variant B) (Human B lymphotropic virus) [45]
Elongation factor G GRLTFLRVY Lactobacillus reuteri (strain DSM 20016) [29]
UvrABC system protein A KREGFVRVQ Lactobacillus reuteri
Aminopeptidase (AP) ERDGFTRVL Erysipelotrichaceae bacterium OTU0002
Amino acid ABC transporter substrate-binding protein KRIAFSRVY Lactobacillus reuteri
Tyr recombinase domain-containing protein PGRRPFTRKELQ Mycolicibacterium paratuberculosis (strain ATCC BAA-968 / K-10) (Mycobacterium paratuberculosis) [12, 15]
Epstein-Barr nuclear antigen 1 PGRRPFFHPVGEAD Epstein-Barr virus (strain B95-8) (HHV-4) (human herpesvirus 4)
Inner tegument protein AVPVLAFDAARLRLLE Epstein-Barr virus (strain B95-8) (HHV-4) (human herpesvirus 4)
Uncharacterized protein (MAP_4027) AVVPVLAYAAARLLL Mycolicibacterium paratuberculosis (strain ATCC BAA-968 / K-10) (Mycobacterium paratuberculosis)
Epsilon-toxin type B TGVSLTTSYSFANTN Clostridium perfringens [27]
Conjugated bile acid hydrolase All of Sequence Clostridium perfringens (strain 13 / Type A) [31]
Conjugated bile acid hydrolase All of Sequence Lactobacillus plantarum (strain ATCC BAA-793 / NCIMB 8826 / WCFS1)
Capsular polysaccharide biosynthesis protein All of Sequence Bacteroides fragilis (strain ATCC 25285 / DSM 2151 / JCM 11019 / NCTC 9343) [30]

Based on [30, 31], Fig 3 shows an alignment of BSH protein sequences from various bacteria, while Fig 4 provides a visual representation of the various enzymes involved in the synthesis of the polysaccharide A.

Fig 3. Alignment of BSH amino acid sequence from the bacteria and associated enzymes that participate in the butyric acid metabolic pathway.

Fig 3

The active site’s amino acids are highlighted in red, based on the structure of the BSH from C. perfringens.

Fig 4. The complex metabolic pathway involved in the production of polysaccharide A, a molecule with potential neuroprotective effects.

Fig 4

Results

Structural similarity analysis

HPV-B19 capsid protein

We used the protein sequence (UniProt accession number Q9PZT0) and tertiary structure (RCSB database accession number 1S58, obtained by X-ray diffraction) of the HPV-B19 capsid protein to perform a structure and sequence alignment with MBP. The sequence alignment of the two proteins is displayed in Fig 5A. The horizontal axis in Fig 5B shows the alignment position, and the vertical axis shows the scoring above eight on alignment. An alignment score of 8.0 or higher is unlikely to occur by random chance, thus suggesting potential functional or structural relevance. Interestingly, Serine and Lysine amino acids were most frequently observed to have an alignment score above 8 in this evaluation.

Fig 5.

Fig 5

a) Amino acid sequence alignment of MBP with the HPV-B19 viral capsid protein. The first line displays the viral capsid amino acid sequence, the second line displays the MBP amino acid sequence, and the third line displays the scores associated with the amino acid alignment between the two sequences. In the amino acid alignment, the colors blue and red represent the gap and identity mode, respectively. Stars represent identity between all aligned amino acids. b) Position-specific scoring matrix for amino acid sequence alignment between HPV-B19 viral capsid protein and MBP protein.

AAV-4 capsid protein

We used the protein sequence (UniProt accession number O41855) and tertiary structure (RCSB database accession number 2G8G, obtained by X-ray diffraction) of the AAV-4 capsid protein to perform a structure and sequence alignment with MBP. We identified AAV-4 for this analysis because the tertiary structure of HPV-B19 and AAV-4 capsid proteins have a root-mean-square deviation (RMSD) of 9.64 for the Cα atoms, consistent with divergence of the protein sequence overall but high similarity in at least some regions. The alignment result of protein sequences is shown in Fig 6A. In Fig 6B, the alignment diagram of section A is drawn, where the horizontal axis shows the alignment position, and the vertical axis shows scoring above eight on alignment. It is noteworthy that the amino acids threonine, asparagine, and glutamine most frequently have high alignment scores in this analysis.

Fig 6.

Fig 6

a) Alignment of AAV-4 viral capsid protein with MBP amino acids sequence. The first line contains the amino acid sequence of the viral capsid coat, while the second line contains the amino acid sequence of the MBP. The third line depicts the consistency of each amino acid alignment from 0 to 10 (star). The similarity and identity of two amino acids are represented by points, with 0 representing the gap mode and a star indicating identity between all aligned amino acids. b) Scoring matrix for aligning amino acid sequences of AAV-4 viral capsid protein and MBP protein.

Tertiary structure alignments

We used the MUSTANG algorithm to align the tertiary structure of the HPV-B19 and AAV-4 capsid proteins and MBP (Fig 7A and 7B). Aligned amino acids with a high score of 8 in Figs 5 and 6 were chosen for evaluation of their 3D position in the two viral capsid protein structures (Fig 8A–8C). The similarity in the aligned positions between the two virus structures is very noticeable on the left side of the images of the two 3D structures. According to the UniProt database, regions 179 to 222 and 246 to 256 have been identified as inducing experimental autoimmune encephalomyelitis (EAE) 1 and 2, respectively. When aligning the MBP sequence with the viral capsid protein structures, certain amino acids in these EAE-associated regions were found to have a score greater than 8. Interestingly, further examination of the 3D structures revealed that despite differences in amino acid sequence, the aligned regions were situated in the same area of the capsid protein structures. As illustrated in Fig 8D, the amino acids corresponding to EAE 1 in the 3D structure of the HPV-B19 viral capsid protein and those corresponding to EAE 2 in the 3D structure of the AAV-4 viral capsid protein were both located in the same region of the 3D structures. These findings suggest a possible conserved, structure-dependent mechanism of molecular mimicry and immune dysregulation in the development of autoimmune encephalitis.

Fig 7.

Fig 7

a) Alignment of tertiary structure between HPV-B19 capsid protein and MBP. b) Alignment of tertiary structure between AAV-4 capsid protein and MBP.

Fig 8.

Fig 8

a) The 3D structure of the HPV-B19 capsid protein with red regions indicating the alignment of amino acids with a score greater than 8 b) The 3D structure of the AAV-4 capsid protein with blue regions indicating the alignment of amino acids with a score greater than 8 c) The alignment of both viral capsid proteins, with overlapping blue and red regions indicating amino acid alignment scores greater than 8. d) The overlapping regions of autoimmune encephalitis-associated amino acids in the HPV-B19 and AAV-4 viral capsid protein structures (GLY82, SER78, THR373, GLY374, SER377, GLN378, GLN379).

Similarity of sequences across microorganisms

Human herpes virus and MBP

In a separate example of potential molecular mimicry, we noted that both the MDRPRTPPPSYSE sequence of the U24 protein from HHV-6 and the similar IVTPRTPPPSQGK sequence of MBP can trigger a response by CD4+ T cells in MS patients [45].

We used this similarity in peptide sequence to search for additional pathogens that could potentially mimic the same epitope. The PRTPPPS sequence present in both proteins was subjected to a BLAST analysis, which yielded sequences from three fungi and one amoeba species (Table 4). To assess the immunogenicity of these sequences and their effect on CD4+ T cells in the immune system, the obtained results were analyzed in the Immune Epitope Database (IEDB), which combines prediction methods for major histocompatibility complex (MHC) binding (using the 7-allele method) [46], and immunogenicity. Since sequences in this database must be at least 15 amino acids long, we used sequences that extended beyond those shown in Table 4. We also examined scores obtained for human leucocyte antigen-DRB1:15:01 (HLA- DRB1:15:01), based on the previously established association between this allele and MS [47]. Table 5 displays the results of this analysis. The score for the MS-associated HLA-DRB:15:01 sequence is high in this analysis, supporting the biological relevance of the IEDB prediction (Table 5). Among the analyzed sequences, Dictyostelium discoideum has a higher immunogenicity score compared to the other sequences.

Table 4. BLAST Peptide of MBP sequence 230 to 236.
Protein sequence (as a study input) and its position
Human 230 PRTPPPS 236 MBP
Protein sequences found using BLAST and their positions
Aspergillus clavatus NRRL1 1124 PSTPPPS 1130 Protein transport protein sec31
Aspergillus fischeri NRRL 181 1110 PSTPPPS 1116 Protein transport protein sec31
Aspergillus fumigatus Af293 1110 PSTPPPS 1116 Protein transport protein sec31
Dictyostelium discoideum 95 PPTPPPS 101 Homeobox protein 12
Table 5. The prediction scores for CD4+ T cell immunogenicity of the analyzed sequences using the CD4+ T cell prediction tool in the IEDB.

The scores for HLA-DRB1:15:01 allele is bolded and underlined as they are important in the association with MS.

Protein Name Organism, Amino acids position Peptide Combined Score Immuno-genicity Score Peptide core Median Percentile Rank (7-allele) HLA-DRB 1:03:01 HLA-DRB 1:07:01 HLA-DRB 1:15:01 HLA-DRB 3:01:01 HLA-DRB 3:02:02 HLA-DRB 4:01:01 HLA-DRB 5:01:01
Protein transport protein sec31 Aspergillus clavatus 1122–1136 YAPSTPPPSQLPMQQ 87.84488 99.6122 YAPSTPPPS 80 93 73 95 77 73 82 80
Aspergillus fischeri, Aspergilllus fumigatus 1108–1122 YAPSTPPPSQLPMQQ 87.84488 99.6122 YAPSTPPPS 80 93 73 95 77 73 82 80
Homeobox protein 12 Dictyostelium discoideum (Slime mold) 92–106 QATPPTPPPSSSSLL 99.99964 99.9991 PTPPPSSSS 100 100 63 100 94 100 94 100
U24 protein human herpesvirus 6A MDRPRTPPPSYSEVL 96.95668 99.8917 DRPRTPPPS 95 97 91 92 88 98 97 95
1–15
MBP Human IVTPRTPPPSQGKGR 97.43512 99.5878 VTPRTPPPS 96 88 98 96 97 95 97 83
227–241

Mice gut flora and the MOG

We then utilized the reported similarities between MOG and Lactobacillus and OUT002 protein sequences (Table 2) to perform a search for additional microorganisms encoding a similar peptide using the BLAST database. The results of this analysis are presented in Table 6. The findings indicate the presence of proteins highly similar to MOG in various bacteria. Several sequences were found from Lactobacillus, which is part of the gut flora and also plays a protective role in the sinus cavities, preventing sinusitis [4850]. Additional sequences include the Clostridium elongating factor, G; a ribosomal protein with cation-dependent endonuclease activity from the bacterium Leptotrix, a bacterium abundant in running water containing iron and manganese [51]; a protein from Oenococcus oeni, a lactic acid bacterium abundant in butter [52]; 6-methylsalicylic acid synthase from Aspergillus species, which is involved in synthesis of patulin toxin [53, 54]; a protein from the thermophilic archaebacterium Methanococcus that performs methanogenic metabolism and participates in biochemical cycles [55]; and elongation factor G from Penicillium species. Two of the Penicillium species in Table 6 can also produce the hazardous patulin toxin, and one of these (known as blue mold), has been linked to apple contamination [56, 57], supporting pathogenicity for at least some of this group of proteins.

Table 6. BLAST results of bacterial proteins.

Organism Sequence information Protein name
Aspergillus clavatus (strain ATCC 1007 / CBS 513.65 / DSM 816 / NCTC 3887 / NRRL 1) 1468 T R AG F T RV L 1475 6-methylsalicylic acid synthase
Methanocaldococcus jannaschii (strain ATCC 43067 / DSM 2661 / JAL-1 / JCM 10045 / NBRC 100440) (Methanococcus jannaschii) 375 K R DG F I RV L 383 Adenine deaminase
Lactobacillus sakei subsp. sakei (strain 23K) 50 L R DG F I RV R 58 SsrA-binding protein
Penicillium expansum (Blue mold rot fungus) 1523 T R DA F N RV L 1531 6-methylsalicylic acid synthase
Penicillium patulum (Penicillium griseofulvum) 1523 T R DA F N RV L 1531 6-methylsalicylic acid synthase
Lactobacillus plantarum 172 K R EG F V RV R 180 UvrABC system protein A (UVRA_LACPL)
Oenococcus oeni (strain ATCC BAA-331 / PSU-1) 332 G R LT F L RV Y 340 Elongation factor G
Lactobacillus fermentum (strain NBRC 3956 / LMG 18251) 324 G R LT F L RV Y 332 Elongation factor G
Clostridium perfringens (strain ATCC 13124 / DSM 756 / JCM 1290 / NCIMB 6125 / NCTC 8237 / Type A) 321 G R LA F T RV Y 329 Elongation factor G
Leptothrix cholodnii (strain ATCC 51168 / LMG 8142 / SP-6) (Leptothrix discophora (strain SP-6)) 50 L R IA F D RV E 58 30S ribosomal protein S16

MAP, EBV, IRF5 proteins and MBP

We performed an analysis using the BLAST database to identify additional hits for the peptide sequences with alignments between Mycolicibacterium paratuberculosis, Epstein-Barr virus, and Homo sapiens (Table 1). The resulting hits were aligned with each of the two sets of similar sequences (Fig 9). We analyzed the protein sequences and conserved sites of each protein (similarity set 1. MAP 0106, EBNA1, and MBP; similarity set 2. MAP 4027, BOLF1, and IRF5) using BLAST (Fig 10 and Table 7). The results reveal additional pathogens with sequences similar to the two groups of MAP and EBV peptide sequences. These pathogens include a species of Aspergillus fungus that causes lung infection [58], where similarity was found for a protein responsible for editing pre-mRNA was identified, and Klebsiella pneumonia, a bacterium that forms part of the normal human mouth, skin, and intestines flora and can cause lung alveoli infections and pneumonia in people with weakened immune systems, where similarity was found to a protein-synthesizing pyrroloquinoline quinone [59]. Similarity to a bromodomain-containing protein from Schizosaccharomyces pombe, the common model organism, was also found [60].

Fig 9.

Fig 9

a) Multiple alignments of MAP_0106, EBNA1, and MBP proteins. b) Multiple alignments of MAP_4027، BOLF1, and IRF5 proteins.

Fig 10. The multiple alignment results based on the two categories presented in Table 7.

Fig 10

a) shows the multiple alignment results of the first group of BLAST protein sequences (EBNA1, MAP 0106, MBP) b) shows the multiple alignment results of the second group of BLAST protein sequences (BOLF1, IRF5, MAP4027).

Table 7. The BLAST results for two categories of protein sequences: 1.

MAP 0106, EBNA1, and MBP and 2. MAP 4027, BOLF1, and IRF5.

Results obtained from the first group (EBNA1, MAP_0106, MBP) HLA-DRB 1:15:01 Score
Organism Sequence information Protein name
Aspergillus fumigatus (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100) 818 PGRRPRGDSLSRSPS 832 Pre-mRNA-splicing factor cwc22 97
Klebsiella pneumoniae 503 PGRRPEAILQAILRQ 517 Coenzyme PQQ synthesis protein F 35
Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast) 346 PGRRPRSMTAPKGGA 360 Bromodomain-containing protein C631.02 82
Burkholderia thailandensis (strain ATCC 700388 / DSM 13276 / CIP 106301 / E264) 128 PGRRPTSTPNRRAPA 142 Endoribonuclease YbeY 93
Burkholderia cenocepacia (strain MC0-3) 25 PGRRPLEWVGMQGID 39 GTP cyclohydrolase FolE2 2 60
Bordetella avium (strain 197N) 436 PGRRPSTLIVLPRMT 450 Glucose-6-phosphate isomerase 43
Results obtained from the second group (BOLF1, IRF5, MAP4027)
Organism Sequence information Protein name
Mycobacterium paratuberculosis (strain ATCC BAA-968 / K-10) 227 AIPVLAQAAGRLRDE 241 Trehalose-phosphate phosphatase 13
Synechocystis sp. (strain PCC 6803 / Kazusa) 19 LVPVLALTASKLLRP 33 NAD(P)H-quinone oxidoreductase subunit 3 3.6
Streptomyces olivaceus 87 LAPVLAYLAGRLLEP 101 Elloramycin glycosyltransferase ElmGT 0.41
Thermosynechococcus vestitus (strain NIES-2133 / IAM M-273 / BP-1) 31 LVPVLALAASALLRP 45 NAD(P)H-quinone oxidoreductase subunit 3 4.3

Two proteins from Borkhdelriaia species were also found to have similarity to the MBP antigen. B. thailandensis is used to model infection of other species of this bacterium family since it is easier to work with and does not require high-level biological facilities. B. cenocepacia causes lung infections in cystic fibrosis patients and is one of the most dangerous pathogens for these patients [61, 62]. Bordetella avium, the final bacterium in the first group, causes a respiratory infection in turkeys by attaching to and spreading to respiratory epithelial cells, a disease is known as Bordetellosis, and is also considered an opportunistic pathogen in patients with cystic fibrosis [63, 64]. A portion of the enzyme glucose 6-phosphate isomerase from this bacterium was found to have similarity to the MBP epitope.

In the second alignment cluster, Trehalose Phosphate Phosphatase from the bacterium MAP, causes tuberculosis and respiratory infections, was identified [65]. The analysis also identified an NAD(P)H-quinone oxidoreductase enzyme from two cyanobacteria, the freshwater single-celled cyanobacterium Synechocystis sp. PCC6803 [66] and Thermosynechococcus elongatus. The elmGT protein of Streptomyces bacteria, which is involved in the biosynthesis of alaromycin and glucose transport, was also identified. Table 7 also shows the probability percentage of each sequence as an epitope of an antigen in CD4+ T cell activation specifically in MS, based on the leukocyte antigen allele HLA-DRB1:15:01 and determined by the IEDB [67]. A previous study also analyzed these sequences for their potential to elicit an immune response in B cell antibodies (Fig 11 and Table 8). The amino acid scores for each sequence are presented in Fig 11, where the horizontal axis of this diagram represents the position of amino acids within each sequence, while the vertical axis represents the corresponding scores for each amino acid.

Fig 11. Diagram of the sequences of epitope antigens obtained from Table 7.

Fig 11

Table 8. The sequences of the antigen as an epitope structure.

Each amino acid from the sequences has a corresponding score in the epitope structure, which is shown in Fig 11. Amino acids with scores higher than the threshold (0.5) in this prediction tool are bolded.

Aspergillus fumigatus Klebsiella pneumoniae Schizosaccharomyces pombe Burkholderia thailandensis Burkholderia cenocepacia Bordetella avium Mycobacterium paratuberculosis Synechocystis sp Streptomyces olivaceus Thermosynechococcus elongatus
P P P P P P A L L L
G G G G G G I V A V
R R R R R R P P P P
R R R R R R V V V V
P P P P P P L L L L
R E R T L S A A A A
G A S S E T Q L Y L
D I M T W L A T L A
S L T P V I A A A A
L Q A N G V G S G S
S A P R M L R K R A
R I K R Q P L L L L
S L G A G R R L L L
P R G P I M D R E R
S Q A A D T E P P P

Correlation of epsilon toxin with MS

Epsilon toxin from Clostridium perfringens has been previously linked to MS primarily based on its known neurotoxic effects and the presence of antibodies against epsilon toxin in some MS patients. The amino acid sequence TGVSLTTSYSFANTN (170–184) of the epsilon protein has been specifically implicated in MS. Using BLAST, a similar sequence was obtained from Nora virus. The two sequences aligned well with each other (Fig 12). The UniProt database indicates that this similar sequence is hosted by the Drosophila Uncharacterized ORF3 protein, which is a member of the Picornavirus family that can infect the intestines of all Drosophila species. The epitope score from IEDB for the antigenic regions of the Nora virus was found to be higher than bacterial epsilon sequences. The amino acids were individually investigated, and their scores were part of the antigen epitope (Fig 13).

Fig 12. Alignment of epsilon toxin of Clostridium perfringens and ORF3 protein of Nora virus.

Fig 12

Fig 13. Sequence analysis of epsilon toxin and ORF3 proteins as an antigen epitope.

Fig 13

The diagram in this figure shows the position of amino acids in each sequence on the horizontal axis and the score of each amino acid on the vertical axis. Also, the amino acids are shown separately, in which their score of them are higher than the threshold, and they were bolded (Table 9).

Table 9. Antigen epitopes derived from Nora virus and Clostridium perfringens-related sequences.

Position Clostridium perfringens Nora virus
1 T T
2 G I
3 V T
4 S S
5 L L
6 T T
7 T T
8 S S
9 Y Y
10 S S
11 F L
12 A A
13 N N
14 T V
15 N P

These findings suggest that the toxin might play a role in MS pathology, although the evidence is not conclusive. Alternatively, this could represent a case of incidental cross-reactivity, where the immune system reacts to epsilon toxin without it being a causative factor in MS.

Spike and protease of SARS-CoV-2

We next explored the similarities between two SARS-CoV-2 proteins and parts of MOG and MBP. First, the sequence similarity of MOG and MBP with the spike glycoprotein of the virus (UniProt ID: P0DTC2) was investigated (Fig 14). Next, alignment of MOG and MBP sequences with the SARS-CoV-2 main protease sequence (UniProt ID: P0DTD1) was carried out (Fig 15).

Fig 14.

Fig 14

a) Sequence alignment of MBP 246–256 with spike glycoprotein 349–359. b) Sequence alignment of 68 to 76 MOG with 28 to 36 spike glycoproteins.

Fig 15.

Fig 15

a) Sequence alignment of MBP 246–256 with main protease 5487–5497. b) Sequence alignment of 68 to 76 MOG with 1975 to 1983 main protease.

Gut microbiota balance

Molecular mimicry between microbial and myelin proteins could initiate or exacerbate autoimmune responses in MS. Therefore, we next examined potential similarities between specific segments of the MOG and MBP sequences and the bile salt hydrolase (BSH) enzyme, and as well as several proteins involved in the metabolism of polysaccharide A was investigated.

BSH enzyme and butyric acid metabolism

We aligned positions 246 to 256 of MBP (which can cause autoimmune encephalitis) and 68 to 76 of MOG (four protected amino acids in a study of mice gut flora by Miyauchi et al. [29]) with the BSH enzyme from various bacterial species present in the gut flora. Specifically, using the data from Fig 3 we aligned the MBP sequence (246 to 256) with the C. perfringens BSH enzyme sequence (Fig 16A) and conducted multiple alignments of MBP sequences with bacterial sequences, including B. longum and L. plantarum (Fig 16B). The results of aligning the active site of the enzyme in a protected part of the sequence are shown in Fig 16. The results revealed the noteworthy presence of Lactobacillus in the alignment.

Fig 16.

Fig 16

a) Alignment of C. perfringens BSH enzyme sequences (227–237) and MBP (from 246 to 256). b) Protected points in the alignment of three bacterial sequences of C. perfringens, B. longum, L. plantarum, and MBP.

In addition to the targeted alignment with MBP, the entire sequence of this protein from the bacterium was aligned with the MOG of mouse and human (Fig 17A). Notably, three out of four protected amino acids in the obtained results were found to be identical (according to list of Table 1). After determining the precise location of the MOG and C. perfringens alignment, a subsequent alignment with the other bacteria (B. longum, L. plantarum) was performed (Fig 17B). The 3D structure of two proteins of B. longum (PDB ID: 2HF0) and C. perfringens (PDB ID: 2RF8), determined by the X-ray diffraction method, exhibited a high degree of similarity (Fig 18). The 3D structure alignment of B. longum and C. perfringens are shown in purple and yellow, respectively. Fig 18 also highlights specific regions in red and green that correspond to motifs from the B. longum and C. perfringens proteins. These motifs were obtained from the result of the sequence alignment of these proteins with the MOG sequence. It is noteworthy that the sequence similarity between the two bacterial proteins is 37%. The alignment of the tertiary structure of these two proteins displayed a significant overlap, and the RMSD between two chains of molecules was 3.53, as calculated for Cα atoms, indicating high similarity.

Fig 17.

Fig 17

a) Alignment of human and mouse MOG with BSH protein from C. perfringens. b) Multiple alignments of MOG with the BSH proteins from C. perfringens, B. longum, and L. plantarum.

Fig 18. 3D structure alignment and motif analysis of B. Longum (purple and red) and C. Perfringens (yellow and green) BSH proteins with MOG sequence.

Fig 18

Polysaccharide A in Bacteroides Fragilis

Finally, we found that certain segments of the MOG sequence bear resemblance to corresponding regions in two proteins implicated in polysaccharide A metabolism. Using the data from Fig 4 MOG was aligned with Wzy, an enzyme of bacterial origin that functions as a polymerase in the periplasmic compartment to facilitate polysaccharide subunit binding (Fig 19), and with glycosyltransferase (WcfQ) (Fig 20). Determination of tertiary structure similarity between these proteins has not been completed.

Fig 19. Relationship between MOG and the Wzy enzyme.

Fig 19

Fig 20. MOG (mouse and human) alignment with the bacterial enzyme WcfQ.

Fig 20

Discussion

In this study, we analyzed public data to identify relationships between proteins or metabolites from microorganisms and the myelin proteins MBP and MOG, since such similarities may represent cases of molecular mimicry that contribute to autoimmunity and MS pathogenesis. We further considered the possibility that microorganism-encoded proteins with known links to MS may have structural similarity with proteins from other microorganisms and even other proteins from the same microorganism. A significant similarity in the secondary structure between HPV-B19 and AAV-4 with MBP was noted, despite sequence differences, highlighting the importance of conservation of secondary structure. Even minimal structural resemblances between MBP, MOG, and pathogenic agents may be sufficient to trigger cross-reactivity, suggesting shared functional motifs. In our comparison of HPV-B19 and AAV-4 capsid proteins with MBP (Fig 8C) we found that, in addition to sequence similarity, three different parts of the tertiary structure of the viral capsid proteins overlap with the MBP structure. Based on the presence of these motifs on the surface of capsid proteins, the observed sequence similarity in the alignment of these motifs, and the potential for the immune system to misidentify them, further laboratory investigations are necessary to understand the role of these antigens in development of MS.

The discovery of conserved molecular mimicry and immune dysregulation mechanisms between HPV-B19 and AAV-4 viruses in the development of autoimmune encephalitis (Fig 8D) raises the possibility that these viral structures may be involved in the initiation and perpetuation of the autoimmune response seen in some individuals with this disease. Understanding the molecular mechanisms underlying autoimmune encephalitis is crucial to developing effective therapies for this debilitating disease.

Antigens that are predicted to stimulate CD4+ cells of the immune system are significant for understanding MS. Three of the pathogens that encode antigens similar to MBP are Aspergillus fischeri, whose genome is very similar to Aspergillus fumigatus, which causes Aspergillosis [68]; Aspergillus clavatus, used in the production of enzymes [69]; and the soil amoebae Dictyostelium discoideum, which is used as a model in immune system studies [70]. All three of these organisms are pathogenic in humans, and also have applications for research and industrial activity. The high score of Dictyostelium compared to the HHV-6 sequence and MBP, predicting CD4+ cell activation and HLA-DRB:15:01 involvement, is noteworthy. All cases scored higher than the HHV-6 sequence itself.

In the case of the MOG sequence, two Penicillium species and one Aspergillus species were found to produce similar antigens, including a 6-methylsalicylic acid synthase, involved in patulin biosynthesis, and multiple instances of Elongation factor G. Proteins from Aspergillus fumigatus, Schizosaccharomyces pombe, and Burkholderia thailandensis scored high for predicting CD4+ activation based on the HLA-DRB1:15:01 allele. These proteins were also predicted in IEDB as antigen epitopes for B cells (Fig 11). Together, this information suggests that these three antigenic sequences have the potential to cause immune system cross-reactivity.

Extensive research on murine coronavirus was conducted prior to the COVID-19 pandemic, specifically on the effect of this coronavirus on the nervous system of mice and the induction of encephalomyelitis. In these studies, demyelination in neurons is structurally similar to human MS disease [7173]. Murine and SARS-CoV-2 viruses belong to the same genus, and new research shows that SARS-CoV-2 remains in the human brain [74]. Based on our sequence alignments between part of MOG and MBP proteins with the spike and protease proteins of the virus, amino acid similarity is exceptionally high for MOG (Figs 14B and 15B). These motifs are located on the surface of the virus proteins in their 3D structure, and could contribute to triggering autoimmunity. Further investigation is warranted to understand the mechanism and effects of this similarity.

This study also identified similarities in the sequences of MBP and MOG with the gut flora enzymes BSH, WcfQ, and Wzy. The findings suggest that an imbalance in the human microbial flora can disrupt metabolite production, potentially leading to biological effects in the body such as in the CNS. Further research is needed to fully understand the link between the human intestinal microbiota and autoimmune conditions.

MBP has been extensively studied in the context of MS, and there is a vast body of literature available on its role in the disease [3, 75]. Our approach was focused on exploring the potential relationship between conserved secondary structures of proteins. We observed a high degree of similarity between the secondary structure of HPV-B19 and AAV-4 with MBP. While there is not always a high degree of primary sequence similarity between MBP and MOG and the proteins encoded by these pathogens, it is important to note that the secondary structure is conserved and is critical to the function of the protein. Therefore, even small similarities in structure between both MBP and MOG and antigenic proteins from pathogens could be significant in terms of understanding potential interactions. There may be motifs and specific regions in the structure of other pathogenic proteins that are similar to those in MBP and MOG. By checking similarities in these structures against reported information on the association between the specific pathogens and MS disease, we can potentially identify specific factors and uncover new relations between MOG and MBP in humans and microorganismal pathogenic agents.

Conclusion

The immune system may mistakenly cross-identify pathogen-encoded and human proteins, contributing to autoimmunity. We show that molecular mimicry of the myelin proteins MBP and MOG by pathogen-encoded proteins can occur due to relatively short, separated amino acid sequences or 3D structure, not just amino acid sequence conservation. We identify additional species and proteins that may also represent cases of molecular mimicry and contribute to MS pathogenesis. We emphasize the importance of investigating the complex relationship between the human intestinal microbiota, viral infections like HPV-B19, AAV-4, and COVID-19, and the development of autoimmune disorders.

Supporting information

S1 Appendix

(PDF)

pone.0308817.s001.pdf (2.3MB, pdf)

Acknowledgments

The authors appreciate the unknown reviewers for valuable and in-depth comments.

Abbreviations

3D

three-dimensional

AAV-4

adeno-associated virus 4

BepiPred-2.0

Bepipred Linear Epitope Prediction 2.0

BLAST

Basic Local Alignment Search Tool

BSH

bile salt hydrolase

CD4

cluster of differentiation 4

CNS

central nervous system

EAE

experimental autoimmune encephalomyelitis

EBV

Epstein-Barr virus

EMBL

European Molecular Biology Laboratory

HHV-6

human herpesvirus 6

HERV

human endogenous retroviruses

HLA

human leukocyte antigens

HPV-B19

human parvovirus B19

IEDB

Immune Epitope Database

IRF-5

interferon regulatory factor 5

MAP

mycobacterium paratuberculosis

MBP

myelin basic protein

MOG

myelin oligodendrocytes glycoprotein

MS

multiple sclerosis

NCBI

National Center for Biotechnology Information

PDB

Protein Data Bank

RCSB

Research Collaboratory for Structural Bioinformatics

RMSD

root-mean-square deviation

WcfQ

glycosyltransferase

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.Goldenberg MM. Multiple Sclerosis Review. Pharm Ther. 2012;37: 175. Available: /pmc/articles/PMC3351877/ [PMC free article] [PubMed] [Google Scholar]
  • 2.Dobson R, Giovannoni G. Multiple sclerosis-a review. Eur J Neurol. 2019;26: 27–40. doi: 10.1111/ene.13819 [DOI] [PubMed] [Google Scholar]
  • 3.Compston A, Coles A. Multiple sclerosis. Lancet (London, England). 2008;372: 1502–1517. doi: 10.1016/S0140-6736(08)61620-7 [DOI] [PubMed] [Google Scholar]
  • 4.Marrodan M, Alessandro L, Farez MF, Correale J. The role of infections in multiple sclerosis. Mult Scler. 2019;25: 891–901. doi: 10.1177/1352458518823940 [DOI] [PubMed] [Google Scholar]
  • 5.Cusick MF, Libbey JE, Fujinami RS. Molecular Mimicry as a Mechanism of Autoimmune Disease. Clin Rev Allergy Immunol. 2012;42: 102. doi: 10.1007/s12016-011-8294-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Rojas M, Restrepo-Jiménez P, Monsalve DM, Pacheco Y, Acosta-Ampudia Y, Ramírez-Santana C, et al. Molecular mimicry and autoimmunity. J Autoimmun. 2018;95: 100–123. doi: 10.1016/j.jaut.2018.10.012 [DOI] [PubMed] [Google Scholar]
  • 7.Xu H, Liu M, Cao J, Li X, Fan D, Xia Y, et al. The Dynamic Interplay between the Gut Microbiota and Autoimmune Diseases. Journal of Immunology Research. Hindawi Limited; 2019. doi: 10.1155/2019/7546047 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Trott S, King IL. An introduction to the microbiome and MS. Mult Scler. 2018. doi: 10.1177/1352458517737391 [DOI] [PubMed] [Google Scholar]
  • 9.Smatti MK, Cyprian FS, Nasrallah GK, Al Thani AA, Almishal RO, Yassine HM. Viruses and autoimmunity: A review on the potential interaction and molecular mechanisms. Viruses. MDPI AG; 2019. doi: 10.3390/v11080762 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Peschl P, Bradl M, Höftberger R, Berger T, Reindl M. Myelin oligodendrocyte glycoprotein: Deciphering a target in inflammatory demyelinating diseases. Frontiers in Immunology. Frontiers Media S.A.; 2017. p. 1. doi: 10.3389/fimmu.2017.00529 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Moscarello MA. Myelin Basic Protein, the “Executive” Molecule of the Myelin Membrane. Cell Biology and Pathology of Myelin. 1997. doi: 10.1007/978-1-4615-5949-8_2 [DOI] [Google Scholar]
  • 12.Mameli G, Cocco E, Frau J, Marrosu MG, Sechi LA. Epstein Barr Virus and Mycobacterium avium subsp. paratuberculosis peptides are recognized in sera and cerebrospinal fluid of MS patients. Sci Rep. 2016;6. doi: 10.1038/srep22401 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Lossius A, Johansen JN, Torkildsen Ø, Vartdal F, Holmoy T. Epstein-Barr Virus in Systemic Lupus Erythematosus, Rheumatoid Arthritis and Multiple Sclerosis—Association and Causation. Viruses 2012, Vol 4, Pages 3701–3730. 2012;4: 3701–3730. doi: 10.3390/V4123701 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Salou M, Garcia A, Michel L, Gainche-Salmon A, Loussouarn D, Nicol B, et al. Expanded CD8 T-cell sharing between periphery and CNS in multiple sclerosis. Ann Clin Transl Neurol. 2015;2: 609–622. doi: 10.1002/acn3.199 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Cossu D, Mameli G, Galleri G, Cocco E, Masala S, Frau J, et al. Human interferon regulatory factor 5 homologous epitopes of Epstein-Barr virus and Mycobacterium avium subsp. paratuberculosis induce a specific humoral and cellular immune response in multiple sclerosis patients. Mult Scler. 2015;21: 984–995. doi: 10.1177/1352458514557304 [DOI] [PubMed] [Google Scholar]
  • 16.Mameli G, Cossu D, Cocco E, Masala S, Frau J, Marrosu MG, et al. Epstein–Barr virus and Mycobacterium avium subsp. paratuberculosis peptides are cross recognized by anti-myelin basic protein antibodies in multiple sclerosis patients. J Neuroimmunol. 2014;270: 51–55. doi: 10.1016/j.jneuroim.2014.02.013 [DOI] [PubMed] [Google Scholar]
  • 17.Lehmann HW, Von Landenberg P, Modrow S. Parvovirus B19 infection and autoimmune disease. Autoimmun Rev. 2003;2: 218–223. doi: 10.1016/s1568-9972(03)00014-4 [DOI] [PubMed] [Google Scholar]
  • 18.Kerr JR. The role of parvovirus B19 in the pathogenesis of autoimmunity and autoimmune disease. J Clin Pathol. 2016;69: 279–291. doi: 10.1136/jclinpath-2015-203455 [DOI] [PubMed] [Google Scholar]
  • 19.Lenglet T, Haroche J, Schnuriger A, Maisonobe T, Viala K, Michel Y, et al. Mononeuropathy multiplex associated with acute parvovirus B19 infection: characteristics, treatment and outcome. J Neurol. 2011;258: 1321–1326. doi: 10.1007/s00415-011-5931-2 [DOI] [PubMed] [Google Scholar]
  • 20.Barbi F, Ariatti A, Funakoshi K, Meacci M, Odaka M, Galassi G. Parvovirus B19 infection antedating Guillain-Barre’ syndrome variant with prominent facial diplegia. J Neurol. 2011;258: 1551–1552. doi: 10.1007/s00415-011-5949-5 [DOI] [PubMed] [Google Scholar]
  • 21.Thomas G, Rael L, Shimonkevitz R, Melamed I, Bar-Or D. Autoantibody Reaction to Myelin Basic Protein by Plasma Parvovirus B19 IgG in MS Patients. Protein Pept Lett. 2005;13: 109–111. doi: 10.2174/092986606775101715 [DOI] [PubMed] [Google Scholar]
  • 22.Wang D, Tai PWL, Gao G. Adeno-associated virus vector as a platform for gene therapy delivery. Nature Reviews Drug Discovery. 2019. doi: 10.1038/s41573-019-0012-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Carter BJ. Adeno-associated Virus and the Development of Adeno-associated Virus Vectors: A Historical Perspective. Mol Ther. 2004;10: 981–989. doi: 10.1016/j.ymthe.2004.09.011 [DOI] [PubMed] [Google Scholar]
  • 24.Li C, Samulski RJ. Engineering adeno-associated virus vectors for gene therapy. Nat Rev Genet 2020 214. 2020;21: 255–272. doi: 10.1038/s41576-019-0205-4 [DOI] [PubMed] [Google Scholar]
  • 25.Donati D. Viral infections and multiple sclerosis. Drug Discov Today Dis Model. 2020;32: 27–33. doi: 10.1016/j.ddmod.2020.02.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Pormohammad A, Azimi T, Falah F, Faghihloo E. Relationship of human herpes virus 6 and multiple sclerosis: A systematic review and meta-analysis. J Cell Physiol. 2018;233: 2850–2862. doi: 10.1002/jcp.26000 [DOI] [PubMed] [Google Scholar]
  • 27.Wagley S, Bokori-Brown M, Morcrette H, Malaspina A, D’Arcy C, Gnanapavan S, et al. Evidence of Clostridium perfringens epsilon toxin associated with multiple sclerosis. Mult Scler. 2019;25: 653. doi: 10.1177/1352458518767327 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Rumah KR, Linden J, Fischetti VA, Vartanian T. Isolation of Clostridium perfringens type B in an individual at first clinical presentation of multiple sclerosis provides clues for environmental triggers of the disease. PLoS One. 2013;8. doi: 10.1371/JOURNAL.PONE.0076359 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Miyauchi E, Kim SW, Suda W, Kawasumi M, Onawa S, Taguchi-Atarashi N, et al. Gut microorganisms act together to exacerbate inflammation in spinal cords. Nature. 2020. doi: 10.1038/s41586-020-2634-9 [DOI] [PubMed] [Google Scholar]
  • 30.Ochoa-Repáraz J, Mielcarz DW, Ditrio LE, Burroughs AR, Begum-Haque S, Dasgupta S, et al. Central Nervous System Demyelinating Disease Protection by the Human Commensal Bacteroides fragilis Depends on Polysaccharide A Expression. J Immunol. 2010;185: 4101–4108. doi: 10.4049/jimmunol.1001443 [DOI] [PubMed] [Google Scholar]
  • 31.Ridlon JM, Kang DJ, Hylemon PB. Bile salt biotransformations by human intestinal bacteria. J Lipid Res. 2006;47: 241–259. doi: 10.1194/jlr.R500013-JLR200 [DOI] [PubMed] [Google Scholar]
  • 32.Burley SK, Bhikadiya C, Bi C, Bittrich S, Chen L, Crichlow G V., et al. RCSB Protein Data Bank: powerful new tools for exploring 3D structures of biological macromolecules for basic and applied research and education in fundamental biology, biomedicine, biotechnology, bioengineering and energy sciences. Nucleic Acids Res. 2021;49: D437–D451. doi: 10.1093/nar/gkaa1038 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol. 1990;215: 403–410. doi: 10.1016/S0022-2836(05)80360-2 [DOI] [PubMed] [Google Scholar]
  • 34.Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, et al. The Protein Data Bank. Nucleic Acids Res. 2000;28: 235–242. doi: 10.1093/nar/28.1.235 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O, et al. Applying and improving AlphaFold at CASP14. Proteins Struct Funct Bioinforma. 2021;89: 1711–1721. doi: 10.1002/prot.26257 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O, et al. Highly accurate protein structure prediction with AlphaFold. Nat 2021 5967873. 2021;596: 583–589. doi: 10.1038/s41586-021-03819-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Simossis VA, Heringa J. PRALINE: A multiple sequence alignment toolbox that integrates homology-extended and secondary structure information. Nucleic Acids Res. 2005. doi: 10.1093/nar/gki390 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Bawono P, Heringa J. PRALINE: A versatile multiple sequence alignment toolkit. Methods Mol Biol. 2014;1079: 245–262. doi: 10.1007/978-1-62703-646-7_16 [DOI] [PubMed] [Google Scholar]
  • 39.Land H, Humble MS. YASARA: A tool to obtain structural guidance in biocatalytic investigations. Methods in Molecular Biology. Humana Press Inc.; 2018. pp. 43–67. doi: 10.1007/978-1-4939-7366-8_4 [DOI] [PubMed] [Google Scholar]
  • 40.Konagurthu AS, Whisstock JC, Stuckey PJ, Lesk AM. MUSTANG: a multiple structural alignment algorithm. Proteins. 2006;64: 559–574. doi: 10.1002/prot.20921 [DOI] [PubMed] [Google Scholar]
  • 41.Clements CS, Reid HH, Beddoe T, Tynan FE, Perugini MA, Johns TG, et al. The crystal structure of myelin oligodendrocyte glycoprotein, a key autoantigen in multiple sclerosis. Proc Natl Acad Sci U S A. 2003;100: 11059–11064. doi: 10.1073/pnas.1833158100 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Jespersen MC, Peters B, Nielsen M, Marcatili P. BepiPred-2.0: improving sequence-based B-cell epitope prediction using conformational epitopes. Nucleic Acids Res. 2017;45: W24–W29. doi: 10.1093/nar/gkx346 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Saha S, Raghava GPS. BcePred: Prediction of continuous B-cell epitopes in antigenic sequences using physico-chemical properties. Lect Notes Comput Sci (including Subser Lect Notes Artif Intell Lect Notes Bioinformatics). 2004;3239: 197–204. doi: 10.1007/978-3-540-30220-9_16/COVER [DOI] [Google Scholar]
  • 44.Kolaskar AS, Tongaonkar PC. A semi-empirical method for prediction of antigenic determinants on protein antigens. FEBS Lett. 1990;276: 172–174. doi: 10.1016/0014-5793(90)80535-q [DOI] [PubMed] [Google Scholar]
  • 45.Tejada-Simon M V., Zang YCQ, Hong J, Rivera VM, Zhang JZ. Cross-reactivity with myelin basic protein and human herpesvirus-6 in multiple sclerosis. Ann Neurol. 2003. doi: 10.1002/ana.10425 [DOI] [PubMed] [Google Scholar]
  • 46.Paul S, Lindestam Arlehamn CS, Scriba TJ, Dillon MBC, Oseroff C, Hinz D, et al. Development and validation of a broad scheme for prediction of HLA class II restricted T cell epitopes. J Immunol Methods. 2015;422: 28–34. doi: 10.1016/j.jim.2015.03.022 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Kular L, Liu Y, Ruhrmann S, Zheleznyakova G, Marabita F, Gomez-Cabrero D, et al. DNA methylation as a mediator of HLA-DRB1*15:01 and a protective variant in multiple sclerosis. Nat Commun 2018 91. 2018;9: 1–15. doi: 10.1038/s41467-018-04732-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.KLAENHAMMER TR, FREMAUX C, AHN C, MILTON K. Molecular Biology of Bacteriocins Produced by Lactobacillus. Bacteriocins of Lactic Acid Bacteria. Elsevier; 1993. pp. 151–180. doi: [DOI] [Google Scholar]
  • 49.Abreu NA, Nagalingam NA, Song Y, Roediger FC, Pletcher SD, Goldberg AN, et al. Sinus microbiome diversity depletion and Corynebacterium tuberculostearicum enrichment mediates rhinosinusitis. Sci Transl Med. 2012;4: 151ra124. doi: 10.1126/scitranslmed.3003783 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Montanari C, Barbieri F, Magnani M, Grazia L, Gardini F, Tabanelli G. Phenotypic diversity of Lactobacillus sakei strains. Front Microbiol. 2018;9: 2003. doi: 10.3389/fmicb.2018.02003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Takeda M, Makita H, Ohno K, Nakahara Y, Koizumi JI. Structural analysis of the sheath of a sheathed bacterium, Leptothrix cholodnii. Int J Biol Macromol. 2005;37: 92–98. doi: 10.1016/j.ijbiomac.2005.09.002 [DOI] [PubMed] [Google Scholar]
  • 52.Mani-López E, Palou E, López-Malo A. Biopreservatives as Agents to Prevent Food Spoilage. Microbial Contamination and Food Degradation. Elsevier; 2018. pp. 235–270. doi: [DOI] [Google Scholar]
  • 53.Hocking AD. Aspergillus and related teleomorphs. Food spoilage microorganisms. Elsevier Ltd; 2006. pp. 451–487. doi: 10.1533/9781845691417.4.451 [DOI] [Google Scholar]
  • 54.Puel O, Galtier P, Oswald IP. Biosynthesis and toxicological effects of patulin. Toxins (Basel). 2010;2: 613–631. doi: 10.3390/toxins2040613 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.DasSarma S, Coker JA, DasSarma P. Archaea (overview). Encyclopedia of Microbiology. Elsevier Inc.; 2009. pp. 1–23. doi: [DOI] [Google Scholar]
  • 56.Nip WK, Chu FS. Production of [14C]patulin by Penicillium patulum. Applied and Environmental Microbiology. American Society for Microbiology (ASM); 1977. pp. 814–816. doi: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Errampalli D. Penicillium expansum (Blue Mold). Postharvest Decay: Control Strategies. Elsevier Inc.; 2014. pp. 189–231. doi: [DOI] [Google Scholar]
  • 58.Sugui JA, Kwon-Chung KJ, Juvvadi PR, Latgé J-P, Steinbach WJ. Aspergillus fumigatus and Related Species. Cold Spring Harb Perspect Med. 2015;5. doi: 10.1101/CSHPERSPECT.A019786 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Suster S, Moran CA. *Klebsiella* Pneumonia. Diagnostic Pathol Thorac. 2017; 530–533. doi: [DOI] [Google Scholar]
  • 60.Johnson EA, Echavarri-Erasun C. Yeast Biotechnology. The Yeasts. 2011;1: 21–44. doi: [DOI] [Google Scholar]
  • 61.P D E M. Burkholderia cenocepacia in cystic fibrosis: epidemiology and molecular mechanisms of virulence. Clin Microbiol Infect. 2010;16: 821–830. doi: 10.1111/J.1469-0691.2010.03237.X [DOI] [PubMed] [Google Scholar]
  • 62.Haraga A, West TE, Brittnacher MJ, Skerrett SJ, Miller SI. Burkholderia thailandensis as a model system for the study of the virulence-associated type III secretion system of burkholderia pseudomallei. Infect Immun. 2008;76: 5402–5411. doi: 10.1128/IAI.00626-08 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Harrington AT, Castellanos JA, Ziedalski TM, Clarridge JE, III, Cookson BT. Isolation of Bordetella avium and Novel Bordetella Strain from Patients with Respiratory Disease. Emerg Infect Dis. 2009;15: 72. doi: 10.3201/EID1501.071677 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Chaves Hernández AJ. Poultry and Avian Diseases. Encycl Agric Food Syst. 2014; 504–520. doi: [DOI] [Google Scholar]
  • 65.Dow CT. Mycobacterium avium Subspecies Paratuberculosis and Human Disease: Bridging Infection and Autoimmunity. Infect Autoimmun. 2015; 569–581. doi: [DOI] [Google Scholar]
  • 66.Yu Y, You L, Liu D, Hollinshead W, Tang YJ, Zhang F. Development of Synechocystis sp. PCC 6803 as a Phototrophic Cell Factory. Mar Drugs. 2013;11: 2894. doi: 10.3390/md11082894 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Moutsianas L, Jostins L, Beecham AH, Dilthey AT, Xifara DK, Ban M, et al. Class II HLA interactions modulate genetic risk for multiple sclerosis. Nat Genet. 2015;47: 1107. doi: 10.1038/ng.3395 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Mead ME, Knowles SL, Raja HA, Beattie SR, Kowalski CH, Steenwyk JL, et al. Characterizing the Pathogenic, Genomic, and Chemical Traits of Aspergillus fischeri, a Close Relative of the Major Human Fungal Pathogen Aspergillus fumigatus. mSphere. 2019;4. doi: 10.1128/mSphere.00018-19 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Shruthi BR, Achur RNH, Nayaka Boramuthi T. Optimized Solid-State Fermentation Medium Enhances the Multienzymes Production from Penicillium citrinum and Aspergillus clavatus. Curr Microbiol 2020 779. 2020;77: 2192–2206. doi: 10.1007/s00284-020-02036-w [DOI] [PubMed] [Google Scholar]
  • 70.Jin T, Xu X, Fang J, Isik N, Yan J, Brzostowski JA, et al. How human leukocytes track down and destroy pathogens: lessons learned from the model organism Dictyostelium discoideum. Immunol Res 2008 431. 2008;43: 118–127. doi: 10.1007/S12026-008-8056-7 [DOI] [PubMed] [Google Scholar]
  • 71.Hosking MP, Lane TE. The pathogenesis of murine coronavirus infection of the central nervous system. Crit Rev Immunol. 2010;30: 119–130. doi: 10.1615/critrevimmunol.v30.i2.20 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Templeton SP, Perlman S. Pathogenesis of acute and chronic central nervous system infection with variants of mouse hepatitis virus, strain JHM. Immunol Res. 2007;39: 160–172. doi: 10.1007/s12026-007-0079-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Phillips JJ, Chua MM, Seo SH, Weiss SR. Multiple regions of the murine coronavirus spike glycoprotein influence neurovirulence. J Neurovirol. 2001;7: 421. doi: 10.1080/135502801753170273 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.MacDougall M, El-Hajj Sleiman J, Beauchemin P, Rangachari M. SARS-CoV-2 and Multiple Sclerosis: Potential for Disease Exacerbation. Front Immunol. 2022;0: 1641. doi: 10.3389/fimmu.2022.871276 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Lassmann H, Brück W, Lucchinetti CF. The Immunopathology of Multiple Sclerosis: An Overview. Brain Pathol. 2007;17: 210–218. doi: 10.1111/j.1750-3639.2007.00064.x [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

S1 Appendix

(PDF)

pone.0308817.s001.pdf (2.3MB, pdf)

Data Availability Statement

All relevant data are within the manuscript and its Supporting Information files.


Articles from PLOS ONE are provided here courtesy of PLOS

RESOURCES